Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula

NCT02425423 is registered in ClinicalTrials.gov with United Pharmaceuticals as lead sponsor.

NCT NCT02425423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02425423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula
Lead sponsor
United Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2013
Completion date
June 30, 2014
Enrollment
100 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux